Other anticoagulants

Citations 1-4 of 4 total displayed.

Most recent content (1 Aug 2009):

Original Articles
Frequency of Allergic or Hematologic Adverse Reactions to Ticlopidine Among Patients With Allergic or Hematologic Adverse Reactions to Clopidogrel

Juzar O. Lokhandwala, Patricia J.M. Best, Joseph H. Butterfield, Kimberly A. Skelding, Thomas Scott, James C. Blankenship, Jeremy W. Buckley, and Peter B. Berger
Circ Cardiovasc Interv 2009;2:348-351; published online before print as doi:10.1161/CIRCINTERVENTIONS.108.832964.108.832964 [Abstract] [Full text]  

Past content (since Apr 2009):

Original Articles
Frequency of Allergic or Hematologic Adverse Reactions to Ticlopidine Among Patients With Allergic or Hematologic Adverse Reactions to Clopidogrel

Juzar O. Lokhandwala, Patricia J.M. Best, Joseph H. Butterfield, Kimberly A. Skelding, Thomas Scott, James C. Blankenship, Jeremy W. Buckley, and Peter B. Berger
Circ Cardiovasc Interv published July 22, 2009, doi:10.1161/CIRCINTERVENTIONS.108.832964.108.832964 [Abstract]  

Original Articles
A Comparison of Abciximab and Small-Molecule Glycoprotein IIb/IIIa Inhibitors in Patients Undergoing Primary Percutaneous Coronary Intervention: A Meta-Analysis of Contemporary Randomized Controlled Trials

Hitinder S. Gurm, Umesh Tamhane, Pascal Meier, P. Michael Grossman, Stanley Chetcuti, and Eric R. Bates
Circ Cardiovasc Interv 2009;2:230-236; published online before print as doi:10.1161/CIRCINTERVENTIONS.108.847996 [Abstract] [Full text]  

Original Article
A comparison of abciximab and small molecule glycoprotein IIb/IIIa inhibitors in patients undergoing primary percutaneous coronary intervention: a meta-analysis of contemporary randomized controlled trials.

Hitinder Gurm, Umesh Tamhane, Pascal Meier, P. Michael Grossman, Stanley J. Chetcuti, and Eric R. Bates
Circ Cardiovasc Interv published April 21, 2009, doi:10.1161/CIRCINTERVENTIONS.108.847996 [Abstract]